Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Former CDC Chief To Head Merck Vaccines Unit
Pharmalot
Monday, December 21, 2009 - 4:18pm
tags:
Merck, CDC, vaccines
Pharma’s Holiday Shopping Spree
CNBC
Monday, December 21, 2009 - 4:15pm
tags:
M&A, Sanofi, Chattem, Teva Pharmaceuticals, OncoGenex, GSK, Seattle Genetics, Incyte, Pfizer, Eli Lilly, Athersys
Indian drugmakers leap ahead with Big Pharma
Fierce Pharma
Monday, December 21, 2009 - 11:50am
tags:
Big Pharma, India, Ranbaxy, Dr Reddy's, Cipla
Seattle Genetics signs development deal with Glaxo
Yahoo/AP
Monday, December 21, 2009 - 11:43am
tags:
GSK, Seattle Genetics, antibodies, liscensing
White House Promises To Allow Drug Imports, After All
Pharmalot
Monday, December 21, 2009 - 11:42am
tags:
healthcare reform, drug importation
Drug stocks climb; Athersys soars on Pfizer deal
Marketwatch
Monday, December 21, 2009 - 11:41am
tags:
Pfizer, Athersys, drug stocks
Why Drug Companies Want to Sell Foot Powder
WSJ Online
Monday, December 21, 2009 - 10:26am
tags:
M&A, Sanofi, Chattem, OTC
Senate nips Botax from healthcare reform
Fierce Pharma
Monday, December 21, 2009 - 10:24am
tags:
Botax, healthcare bill, healthcare reform, Senate
Obituaries I: Altus Becomes a Casualty of Development Costs, but Drug May Live On
BNET Pharma
Monday, December 21, 2009 - 10:07am
tags:
Altus, Trizytek
Facet Rebuffs Biogen: Will a White Knight Emerge?
Seeking Alpha
Monday, December 21, 2009 - 10:06am
tags:
Facet Biotech, M&A, Biogen Idec, Abbott Laboratories
Teva, OncoGenex sign drug development deal
Yahoo/AP
Monday, December 21, 2009 - 9:57am
tags:
Teva Pharmaceuticals, OncoGenex, drug development, partnerships
Actelion Shares Sink On Almorexant Safety Woes
WSJ Online
Monday, December 21, 2009 - 9:47am
tags:
Actelion, drug safety, almorexant, insomnia
Novartis Shifts Focus to Rare Diseases
WSJ Online
Monday, December 21, 2009 - 9:34am
tags:
Novartis, Daniel Vasella, Pharma CEOs
Pfizer Acquires a Stem-Cell Therapy
NY Times, NY
Monday, December 21, 2009 - 9:29am
tags:
Pfizer, stem cells, MultiStem, M&A
Lilly inks licensing deal for Incyte drug
Marketwatch
Monday, December 21, 2009 - 9:27am
tags:
Incyte, Eli Lilly, liscensing, rheumatoid arthritis
A Window of Opportunity to Buy Emisphere
Seeking Alpha
Monday, December 21, 2009 - 9:15am
tags:
Emisphere, Calcitonin
Sanofi-Aventis Stops Development of Two Medicines
Bloomberg
Monday, December 21, 2009 - 9:11am
tags:
Sanofi, insomnia, anti-clotting, prostate cancer, atrial fibrillation
Sanofi-Aventis to Buy Chattem for $1.9B
TheStreet.com
Monday, December 21, 2009 - 9:10am
tags:
Sanofi, M&A, Chattem
NovaBay Pharmaceuticals to Receive Increase in Funding and Support From Alcon
PR-Canada
Sunday, December 20, 2009 - 11:17am
tags:
NovaBay Pharmaceuticals, Alcon
Alexza Moves Forward with AZ-004 Anti-Psychotic Drug
Seeking Alpha
Sunday, December 20, 2009 - 11:05am
tags:
Alexza, antipsychotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.